Drugs / High ACE Activity Fresh Frozen Plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04679311 | Dec 2020 → Jan 2023 | renin-angiotensin-aldosterone system-blocker-induced angioedema | Washington University School of Medicine | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High ACE Activity Fresh Frozen Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04679311 ↗ |
| Action | Activate | “will increase serum ACE activity” NCT04679311 ↗ |